This 2019 analysis from the CORE 320 trial assessed 379 symptomatic patients aged 45–85 undergoing coronary artery calcium (CAC) scanning and CT angiography to evaluate the predictive value of different CAC metrics for major adverse cardiac events (MACE) over a two-year follow-up. Among the parameters studied—Agatston score, calcium volume, area,